On April 24, 2020, the Federal Trade Commission (“FTC”) filed a complaint in federal court as well as an administrative complaint against California-based marketer, Whole Leaf Organics for its unsubstantiated product claims.1 The company sells Thrive, a supplement consisting mainly of vitamin C and … Read more about FTC Sues Company for Unsubstantiated Claims
DEA Removes CBD from Controlled Substances Act
On Monday, April 6, GW Pharmaceuticals revealed that the company had received notice from the U.S. Drug Enforcement Administration (“DEA”) stating that its drug Epidiolex was no longer subject to the requirements of the Controlled Substances Act (“CSA”). In a company release announcing the agency … Read more about DEA Removes CBD from Controlled Substances Act
Vape and E-Cigarette Manufacturers Catch Another Break
This week, in a letter to federal Judge Paul Grimm, the U.S. Food and Drug Administration (“FDA”) requested a 120-day extension for e-cigarette product applications, citing the unforeseen impact of the novel coronavirus (“COVID-19”). This marks the most recent instance in a long line of delays, both … Read more about Vape and E-Cigarette Manufacturers Catch Another Break
FDA Recognizes the Need for CBD Regulation
On February 26, 2020 the Food and Drug Administration’s (“FDA”) new commissioner, Dr. Stephen Hahn, acknowledged the growing consumer demand for CBD products. “People are using these [CBD] products,” Hahn said in his first public speech regarding CBD since taking office in December. “We are not … Read more about FDA Recognizes the Need for CBD Regulation
D.C. Court Supports FDA Regulation of E-Cigs & Vape Products
On 10, December 2019, the United States Court of Appeals for the D.C. Circuit ruled in support of actions by the Food and Drug Administration (“FDA”) on the regulation and classification of electronic nicotine delivery system (“ENDS”) products like electronic cigarettes and vaping devices. The … Read more about D.C. Court Supports FDA Regulation of E-Cigs & Vape Products
New Screening Guidelines for Fecal Transplants Could Save Lives
The Food and Drug Administration (“FDA”) has recently set guidelines on an increasingly common medical treatment: fecal microbiota transplants, or FMTs. The recent announcement comes after a patient died in June after receiving an FMT that contained drug-resistant bacteria.1 Unfortunately, up until … Read more about New Screening Guidelines for Fecal Transplants Could Save Lives
FDA Plans Public Hearing on Ingestible CBD Products
Last Wednesday, at a hearing held by the House Appropriations Committee, U.S. Food and Drug Administration (“FDA”) Commissioner Scott Gottlieb revealed the FDA’s plan to conduct public hearings on cannabidiol (“CBD”) starting in April. Acknowledging the legalization of hemp and hemp-derived products … Read more about FDA Plans Public Hearing on Ingestible CBD Products
The Agricultural Improvement Act of 2018 & Federal Trademarks
Securing federal trademark protection for products derived from industrial hemp has proven to be a challenge for many in the industry. The United States Patent and Trademark Office (the “USPTO) categorically denies any trademark application that is submitted for an “illegal” product or service.1 Up … Read more about The Agricultural Improvement Act of 2018 & Federal Trademarks